<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: NBY News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=nby</link><description>Latest Financial News for NOVABAY PHARMACEUTCL</description><language>en-us</language><lastBuildDate>Wed, 23 Dec 2009 22:20:46 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091223/nby8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/570015670</guid><pubDate>Wed, 23 Dec 2009 22:20:46 Etc/GMT</pubDate></item><item><title>NovaBay Pharmaceuticals to Receive Increase in Funding and Support From Alcon (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091217/0570016.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1977381199</guid><pubDate>Thu, 17 Dec 2009 12:00:00 Etc/GMT</pubDate></item><item><title>NOVABAY PHARMACEUTICALS, INC. Financials (EDGAR Online Financials)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=nby</link><description></description><guid isPermaLink="false">yahoo_finance/3006163021</guid><pubDate>Tue, 17 Nov 2009 14:04:34 Etc/GMT</pubDate></item><item><title>New Star Analyst Rankings for NOVABAY PHARMACEUTCL (StarMine)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/a/r/n/nby.html</link><description></description><guid isPermaLink="false">yahoo_finance/3976758748</guid><pubDate>Mon, 16 Nov 2009 14:26:33 Etc/GMT</pubDate></item><item><title>NovaBay Pharmaceuticals Reports Third Quarter Financials and Provides Update on Pipeline of Anti-Infective Compounds (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091113/0558847.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1180340560</guid><pubDate>Fri, 13 Nov 2009 14:00:00 Etc/GMT</pubDate></item><item><title>NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091112/nby10-q.html</link><description></description><guid isPermaLink="false">yahoo_finance/3823340434</guid><pubDate>Thu, 12 Nov 2009 17:31:16 Etc/GMT</pubDate></item><item><title>NovaBay&apos;s Aganocides Show Penetration and Efficacy in a Pre-Clinical Infected Human Nail Model of Onychomycosis (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091030/sf02327.html?.v=1</link><description>NovaBay Pharmaceuticals, Inc. today announced that its Aganocide® compounds demonstrate potent antifungal activity in an established pre-clinical infected nail model of onychomycosis.</description><guid isPermaLink="false">yahoo_finance/3565889357</guid><pubDate>Fri, 30 Oct 2009 13:30:00 Etc/GMT</pubDate></item><item><title>NovaBay to Hold Conference Call to Review Aganocide Data Presented at the Infectious Diseases Society of America Meeting (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091028/sf00539.html?.v=1</link><description>NovaBay Pharmaceuticals, Inc. will hold a webcast conference call on October 30, 2009 to review preclinical data from a study of Aganocide® product candidates NVC-422 and NVC-612 in a model of onychomycosis, commonly termed nail fungus.</description><guid isPermaLink="false">yahoo_finance/1488386695</guid><pubDate>Wed, 28 Oct 2009 11:30:00 Etc/GMT</pubDate></item><item><title>NovaBay Pharmaceuticals to Present at 8th Annual Bio Investor Forum 2009 in San Francisco (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091022/sf97058.html?.v=1</link><description>NovaBay Pharmaceuticals, Inc. http://www.novabaypharma.com, a clinical stage company developing non-antibiotic antimicrobial compounds for the treatment or prevention of a wide range of bacterial, viral and fungal infections, today announced that Thomas Paulson, Chief Financial Officer, will deliver a corporate presentation at the Bio Investor Forum 2009 being held at The Palace Hotel in San Francisco.</description><guid isPermaLink="false">yahoo_finance/3447938191</guid><pubDate>Thu, 22 Oct 2009 11:00:00 Etc/GMT</pubDate></item><item><title>NovaBay hires chief scientific officer (at bizjournals.com)</title><link>http://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12jd8lb4i/*http%3A//sanfrancisco.bizjournals.com/sanfrancisco/stories/2009/10/19/daily1.html?ana=yfcpc</link><description></description><guid isPermaLink="false">yahoo_finance/1441574981</guid><pubDate>Mon, 19 Oct 2009 17:05:22 Etc/GMT</pubDate></item><item><title>NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091019/sf94442.html?.v=1</link><description>NovaBay Pharmaceuticals, Inc. , a clinical stage company developing non-antibiotic anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral, and fungal infections, today announced that the company has named Mark Anderson, Ph.D. as chief scientific officer, a new position for the company.</description><guid isPermaLink="false">yahoo_finance/4238079577</guid><pubDate>Mon, 19 Oct 2009 11:00:00 Etc/GMT</pubDate></item><item><title>NovaBay Pharmaceuticals Announces the Closing of Its $2.45 Million Registered Direct Offering of Common Stock and Warrants (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090826/0531432.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/796382407</guid><pubDate>Wed, 26 Aug 2009 21:09:00 Etc/GMT</pubDate></item><item><title>NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090821/nby8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/411206645</guid><pubDate>Fri, 21 Aug 2009 21:28:40 Etc/GMT</pubDate></item><item><title>NovaBay Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering of Common Stock and Warrants (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090821/0530156.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2029125960</guid><pubDate>Fri, 21 Aug 2009 14:26:00 Etc/GMT</pubDate></item><item><title>NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090814/nby10-q.html</link><description></description><guid isPermaLink="false">yahoo_finance/1143224554</guid><pubDate>Fri, 14 Aug 2009 10:06:55 Etc/GMT</pubDate></item><item><title>NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-Q/A, Quarterly Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090804/nby10-q_a.html</link><description></description><guid isPermaLink="false">yahoo_finance/1061430443</guid><pubDate>Tue, 4 Aug 2009 21:06:40 Etc/GMT</pubDate></item><item><title>NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090803/nby8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/1334421325</guid><pubDate>Mon, 3 Aug 2009 20:38:37 Etc/GMT</pubDate></item><item><title>NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090515/nby10-q.html</link><description></description><guid isPermaLink="false">yahoo_finance/589964602</guid><pubDate>Fri, 15 May 2009 19:41:11 Etc/GMT</pubDate></item><item><title>NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090331/nby10-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3563344864</guid><pubDate>Tue, 31 Mar 2009 21:04:17 Etc/GMT</pubDate></item><item><title>NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090325/nby8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2792655642</guid><pubDate>Wed, 25 Mar 2009 16:47:05 Etc/GMT</pubDate></item></channel></rss><!-- c16.finance.sp2.yahoo.com compressed/chunked Thu Dec 24 04:48:09 PST 2009 -->
